468 related articles for article (PubMed ID: 31258091)
1. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
Fragoulis GE; Panayotidis I; Nikiphorou E
Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Risk of Synthetic, Non-Biologic Disease-Modifying Anti- Rheumatic Drugs (DMARDs).
Mourouzis IS; Manolis AS; Pantos C
Curr Vasc Pharmacol; 2020; 18(5):455-462. PubMed ID: 31566134
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Disease in Spondyloarthritides.
Papagoras C; Voulgari PV; Drosos AA
Curr Vasc Pharmacol; 2020; 18(5):473-487. PubMed ID: 31330576
[TBL] [Abstract][Full Text] [Related]
4. New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis.
Mahmoudi M; Aslani S; Fadaei R; Jamshidi AR
Int J Rheum Dis; 2017 Mar; 20(3):287-297. PubMed ID: 28205331
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
Giollo A; Bissell LA; Buch MH
Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
Drakopoulou M; Soulaidopoulos S; Oikonomou G; Tousoulis D; Toutouzas K
Curr Vasc Pharmacol; 2020; 18(5):488-506. PubMed ID: 32056527
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
[TBL] [Abstract][Full Text] [Related]
8. Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.
Chighizola C; Schioppo T; Ingegnoli F; Meroni PL
Curr Vasc Pharmacol; 2012 Sep; 10(5):639-46. PubMed ID: 22272912
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease and rheumatoid arthritis: an update.
Charles-Schoeman C
Curr Rheumatol Rep; 2012 Oct; 14(5):455-62. PubMed ID: 22791398
[TBL] [Abstract][Full Text] [Related]
10. Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.
Amezaga Urruela M; Suarez-Almazor ME
Curr Rheumatol Rep; 2012 Oct; 14(5):428-37. PubMed ID: 22802154
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis (RA) and cardiovascular disease.
Blum A; Adawi M
Autoimmun Rev; 2019 Jul; 18(7):679-690. PubMed ID: 31059840
[TBL] [Abstract][Full Text] [Related]
12. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis?
Pieringer H; Pichler M; Pohanka E; Hoppe UC
Curr Pharm Des; 2014; 20(4):486-95. PubMed ID: 23565635
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease in rheumatoid arthritis: a step forward.
Myasoedova E; Gabriel SE
Curr Opin Rheumatol; 2010 May; 22(3):342-7. PubMed ID: 20164773
[TBL] [Abstract][Full Text] [Related]
14. [Rheumatoid arthritis: a cardiovascular disease?].
Daïen CI; Fesler P
Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):111-7. PubMed ID: 21885031
[TBL] [Abstract][Full Text] [Related]
15. The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study.
Sandoo A; Protogerou AD; Hodson J; Smith JP; Zampeli E; Sfikakis PP; Kitas GD
Arthritis Res Ther; 2012 Nov; 14(6):R258. PubMed ID: 23190682
[TBL] [Abstract][Full Text] [Related]
16. Prevention of cardiovascular disease in rheumatoid arthritis.
Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
[TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions.
Ferguson LD; Siebert S; McInnes IB; Sattar N
Nat Rev Rheumatol; 2019 Aug; 15(8):461-474. PubMed ID: 31292564
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?
Day AL; Singh JA
Drugs Aging; 2019 Jun; 36(6):493-510. PubMed ID: 30953327
[TBL] [Abstract][Full Text] [Related]
19. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.
Myasoedova E; Chandran A; Ilhan B; Major BT; Michet CJ; Matteson EL; Crowson CS
Ann Rheum Dis; 2016 Mar; 75(3):560-5. PubMed ID: 25637001
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory arthritis as a novel risk factor for cardiovascular disease.
John H; Kitas G
Eur J Intern Med; 2012 Oct; 23(7):575-9. PubMed ID: 22841864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
